In the last three months, 9 analysts have published ratings on Zimmer Biomet Holdings (NYSE:ZBH), offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 2 | 6 | 1 | 0 |
| Last 30D | 0 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 2 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 3 | 1 | 0 |
Analysts have set 12-month price targets for Zimmer Biomet Holdings, revealing an average target of $135.0, a high estimate of $155.00, and a low estimate of $125.00. Observing a 3.39% increase, the current average has risen from the previous average price target of $130.57.
Decoding Analyst Ratings: A Detailed Look
The standing of Zimmer Biomet Holdings...
Login or create a forever free account to read this news
Sign up/Log in